Correlation Engine 2.0
Clear Search sequence regions

  • case report (2)
  • dna (1)
  • factor ix (3)
  • factor ix leyden (1)
  • fix (7)
  • follow up studies (1)
  • hematoma (1)
  • hemophilia (1)
  • hemophilia b (9)
  • humans (1)
  • japan (3)
  • male (2)
  • parents (1)
  • patients (1)
  • period (1)
  • regions (1)
  • traumatic (1)
  • young adult (1)
  • Sizes of these terms reflect their relevance to your search.

    Hemophilia B Leyden is a unique subtype of hemophilia B, characterized by increasing factor IX activity (FIX:C) after puberty and a lower normal range of FIX:C throughout adulthood. However, to date, no Japanese case has been reported. Here, we report a case of hemophilia B Leyden in a 22-year-old male. He suffered from subgaleal hematoma, and was subsequently diagnosed with hemophilia B (FIX:C 0.2%) in the neonatal period. Both his parents are Japanese. There was no history of hemophilia in his family. FIX:C gradually increased with age (8% at age = 1; 14% at age = 7; 19% at age = 12; 32% at age = 18). FIX:C is within the range 30-40% in recent several years. He once required administration of FIX concentrate against traumatic tongue bleeding at 7 years of age. Genotyping analysis of FIX was performed after informed consent at 21 years of age, and a point mutation (c.-35G>A) was detected. This mutation has been reported previously as the Leyden mutation. Although it has been reported that hemophilia B Leyden is seen in 1.9% of patients with hemophilia B, the present case is the first report of hemophilia B Leyden from Japan.


    Atsuki Yamashita, Chiai Nagae, Mika Mori, Tomoko Ashikaga, Tetsuhito Kojima, Masashi Taki. First case report of hemophilia B Leyden in Japan. International journal of hematology. 2017 Jul;106(1):135-137

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 28168417

    View Full Text